New Horizon Capital (新天域资本) is a China-focused private equity fund, with a particular emphasis on businesses in less developed and less penetrated Tier II and Tier III cities in China.
Phone: +852 2801 6988
Suites 1702-03, 17/F One Exchange Square
8 Connaught Place
Central,
Hong Kong
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2019-12-04 | Huangdouxia | Series A | $9.92M | |
2019-07-18 | Ke Holdings | Series D | $1.2B | China Renaissance, Country Garden, Gaw Capital Partners, Hillhouse Capital Management, Source Code Capital, Strait Capital Investment Group, and Tencent Holdings |
2019-04-16 | Energy Monster | Series C | $74.5M | Advantech Capital, BOC International, Goldman Sachs, Hillhouse Capital Management, Jiawei Gan, Shunwei Capital Partners, Sky9 Capital, Softbank Ventures Asia, and Xiaomi |
2017-07-06 | Maijie Translational Medicine Research | Series A | $25.72M | Anjie Investment, Qiming Venture Partners, Quan Capital, and Shanghai Jiemao Medical Apparatus and Instruments |
2017-05-15 | Wacai | Series C | $42M | Ally Bridge Group, China Broadband Capital, China Development Bank Capital, and Qiming Venture Partners |